您当前的位置：
首页 >
文章列表页 >
Clinical observation of evolocumab combined with atorvastatin in the treatment of borderline coronary artery disease
更新时间：2026-05-26

    • Clinical observation of evolocumab combined with atorvastatin in the treatment of borderline coronary artery disease

    • ZHONGGUO YAOFANG   Vol. 37, Issue 10, Pages: 1318-1322(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.10.14    

      CLC： R969.4;R541.4

    • Received：12 January 2026，

      Revised：2026-04-17，

      Accepted：19 April 2026，

      Published：30 May 2026

    移动端阅览

  • SU Ruiya,WANG Lichuang,ZHANG Ou,et al.Clinical observation of evolocumab combined with atorvastatin in the treatment of borderline coronary artery disease[J].ZHONGGUO YAOFANG,2026,37(10):1318-1322. DOI： 10.6039/j.issn.1001-0408.2026.10.14.

  •  
  •  

0

Views

15

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效和安全性比较
瑞舒伐他汀与阿托伐他汀对冠心病患者血脂、动脉粥样硬化程度和血管内皮舒张功能的疗效对比
Construction and validation of a medication deviation prediction model for hospital-to-home transition period in coronary heart disease patients with initial treatment
Clinical rapid evaluation of proprotein convertase subtilisin/kexin type 9 inhibitors for hypercholesterolemia
前列腺素E1联合阿托伐他汀对老年高血压肾病患者相关指标的

Related Author

ZHANG Like
CHEN Yu
YAO Lijun
CHEN Tan
LI Yushuang
LI Shu
ZHANG Qianying
HUANG Yan

Related Institution

Dept. of Pharmacy， the Affiliated Hospital of North China University of Science and Technology
School of Pharmacy， North China University of Science and Technology
Dept. of Pharmacy， the Second Affiliated Hospital of Hebei Northern University
School of Medicine， University of Electronic Science and Technology of China
Dept. of Pharmacy， Sichuan Academy of Medical Sciences， Sichuan Provincial People’s Hospital （Affiliated Hospital of University of Electronic Science and Technology of China）/Personalized Drug Research and Therapy Key Laboratory of Sichuan Province
0